- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.11. | Ali Parsa is back in digital health with start-up Quadrivia | ||
| 13.11. | London "is number one European city in life sciences" | ||
| 13.11. | Daiichi and AZ pull Dato-DXd filing with FDA and try again | ||
| 12.11. | Neurogene shares fall on Rett syndrome gene therapy data | ||
| 12.11. | Merck KGaA drug for rare tumour hits phase 3 target | ||
| 12.11. | Chasing $80bn sales target, AZ unveils $3.5bn US investment | ||
| 12.11. | NHS England relaunches anti-smoking pill programme | ||
| 12.11. | 23andMe ends drug development and slashes staff | ||
| 11.11. | Unicycive eyes June FDA verdict for hyperphosphataemia drug | ||
| 11.11. | Advantage BMS as AbbVie drug fails schizophrenia trials | ||
| 11.11. | Trump win casts pall over future of Affordable Care Act | ||
| 11.11. | Autolus bags FDA approval for leukaemia cell therapy | ||
| 11.11. | AI tool spots long COVID in electronic health records | ||
| 11.11. | Aignostics leads latest crop of digital health financings | ||
| 08.11. | Eisai dials back forecasts for Alzheimer's drug Leqembi | ||
| 08.11. | Daiichi Sankyo partners Alteogen on subcutaneous Enhertu | ||
| 08.11. | AZ confirms China president has been detained | ||
| 08.11. | NHS Wales partners with Illumina on genomics drive | ||
| 08.11. | UK health data ecosystem 'is hampering research' | ||
| 07.11. | Sarepta pulls plug on Duchenne exon-skipping drug | ||
| 07.11. | Blueprint's mastocytosis drug Ayvakit cleared for NHS use | ||
| 07.11. | Novo sheds kidney drug licensed for $1.3bn a year ago | ||
| 07.11. | Avid Bioservices to go private in $1.1bn private equity deal | ||
| 07.11. | XRHealth buys NeuroReality in health XR marriage | ||
| 06.11. | Alligator pancreatic cancer drug 'nearly doubles' survival |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
